Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annie Burden

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Allergy, Asthma & Immunology Research|July 4, 2012
Effectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary careDavid Price, Henry Chrystyn, Alan Kaplan, et al.
The Lancet. Respiratory Medicine|December 28, 2020
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trialTim W Harrison, Pascal Chanez, Francesco Menzella, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 22, 2023
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice SubstudyRenaud Louis, Tim W Harrison, Pascal Chanez, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|June 16, 2021
Predicting asthma-related crisis events using routine electronic healthcare data: a quantitative database analysis studyMichael Noble, Annie Burden, Susan Stirling, et al.
The Lancet. Respiratory Medicine|October 7, 2021
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm studyAndrew Menzies-Gow, Mark Gurnell, Liam G Heaney, et al.
The European Respiratory Journal|July 27, 2022
Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE studyAndrew Menzies-Gow, Mark Gurnell, Liam G Heaney, et al.
The Lancet Regional Health. Europe|April 24, 2023
Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI studyKausik K Ray, Inaam Haq, Aikaterini Bilitou, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Allergy, Asthma & Immunology Research|July 4, 2012
Effectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary careDavid Price, Henry Chrystyn, Alan Kaplan, et al.
The Lancet. Respiratory Medicine|December 28, 2020
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trialTim W Harrison, Pascal Chanez, Francesco Menzella, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 22, 2023
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice SubstudyRenaud Louis, Tim W Harrison, Pascal Chanez, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|June 16, 2021
Predicting asthma-related crisis events using routine electronic healthcare data: a quantitative database analysis studyMichael Noble, Annie Burden, Susan Stirling, et al.
The Lancet. Respiratory Medicine|October 7, 2021
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm studyAndrew Menzies-Gow, Mark Gurnell, Liam G Heaney, et al.
The European Respiratory Journal|July 27, 2022
Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE studyAndrew Menzies-Gow, Mark Gurnell, Liam G Heaney, et al.
The Lancet Regional Health. Europe|April 24, 2023
Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI studyKausik K Ray, Inaam Haq, Aikaterini Bilitou, et al.
Pageof 2